Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Mannucci, P.M.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(19)
+
-
Availability
Open access
(9)
+
-
Metadata Only
(11)
+
-
Creation Date
2018
(4)
+
-
2017
(3)
+
-
2020
(3)
+
-
2014
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(19)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(19)
+
-
Topic
factor VIII
(3)
+
-
von Willebrand disease
(3)
+
-
hemophilia A
(2)
+
-
inhibitor
(2)
+
-
von Willebrand factor
(2)
+
-
Author
Mannucci, P.M.
(20)
+
-
Peyvandi, F.
(17)
+
-
Rosendaal, F.R.
(16)
+
-
Palla, R.
(8)
+
-
Eshghi, P.
(6)
+
-
Garagiola, I.
(6)
+
-
Castaman, G.
(5)
+
-
Federici, A.B.
(5)
+
-
Karimi, M.
(5)
+
-
Badiee, Z.
(4)
+
-
Baghaipour, M.R.
(4)
+
-
Baronciani, L.
(4)
+
-
Budde, U.
(4)
+
-
Fernandez, M.F.L.
(4)
+
-
Goudemand, J.
(4)
+
-
Keikhaei, B.
(4)
+
-
Lassila, R.
(4)
+
-
Leebeek, F.W.G.
(4)
+
-
Peake, I.
(4)
+
-
Schneppenheim, R.
(4)
+
-
Tiede, A.
(4)
+
-
Toogeh, G.
(4)
+
-
Tosetto, A.
(4)
+
-
Trossaert, M.
(4)
+
-
Zetterberg, E.M.K.
(4)
+
-
Ahmadinejad, M.
(3)
+
-
Bodo, I.
(3)
+
-
Cannavo, A.
(3)
+
-
Eikenboom, J.
(3)
+
-
Marino, R.
(3)
+
-
Mazzucconi, M.G.
(3)
+
-
Oldenburg, J.
(3)
+
-
Santoro, C.
(3)
+
-
Valsecchi, C.
(3)
+
-
Bucciarelli, P.
(2)
+
-
El-Beshlawy, A.
(2)
+
-
Elalfy, M.
(2)
+
-
Goodeve, A.
(2)
+
-
Hidalgo, O.B.
(2)
+
-
Hoorfar, H.
(2)
+
-
Morfini, M.
(2)
+
-
O'Mahony, B.
(2)
+
-
Pagliari, M.T.
(2)
+
-
Ramanan, V.
(2)
+
-
SIPPET Study Grp
(2)
+
-
Yadegari, H.
(2)
+
-
Show more
Language
en
(20)
+
-
Search results
(1 - 20 of 20)
show grid
show list
save search
Von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia A
Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease
Thrombo-inflammation in cardiovascular disease
PERFORMANCE OF A CLINICAL RISK PREDICTION MODEL FOR INHIBITOR FORMATION IN SEVERE HEMOPHILIA A
High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis
Choices of factor VIII products in previously untreated patients with haemophilia A: A global survey
Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement
Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis
SIPPET: methodology, analysis and generalizability
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
The importance and challenge of pediatric trials of hemophilia drugs Reply
Pediatric requirements in Europe stymie help for hemophilia
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factors
Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis - Results from a multicenter study in 47 patients